Table: Daito -2023/24 group forecast
Jun 25 (Reuters) -
Daito Pharamaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
May 31, 2024 May 31, 2024
LATEST PREVIOUS
FORECAST FORECAST
Sales 46.85 47.50
Operating 3.85 4.80
Recurring 3.90 4.80
Net 3.25 3.30
EPS 207.12 yen 208.82 yen
NOTE - Daito Pharamaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T
Recent news on Daito Pharmaceutical
See all newsTo Buy Back Up To 4.4% Of Own Shares Worth 2 Billion Yen
Table: Daito Pharmaceutical -Q1 group results
Execution Of JV And Share Transfer Agreement For Transfer Of Kyorin Pharmaceutical's Generic Drug Business To JV By Daito, Meiji Seika Pharma And Dbj
Table: Daito -2025/26 parent results
Table: Daito -2025/26 group results